N-of-One Selected by Life Technologies to Provide Valuable Employee Benefit: Molecular Diagnostics and Treatment Strategies for Personalized Cancer Care

Published: Oct 16, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WALTHAM, Mass.--(BUSINESS WIRE)--N-of-One, Inc., a leading provider of molecular interpretation and therapeutic strategies for personalized cancer care, today announced that global life sciences company Life Technologies (NASDAQ: LIFE) has selected N-of-One to provide a new type of benefit to its approximately 10,000 employees. For the first time, Life Technologies employees will have confidential access to personalized cancer treatment strategies as an employee benefit, including review of the most advanced treatment options available. N-of-One develops comprehensive molecular diagnostic strategies for physicians and their patients, and based on the findings of the testing, prepares comprehensive treatment reports outlining the therapeutic options available to the patients and their oncologists. The financial terms of the agreement are not disclosed.

Help employers find you! Check out all the jobs and post your resume.

Back to news